The major reason is serious data has not been rele
Post# of 30028
Posted On: 08/26/2014 11:26:38 AM
The major reason is serious data has not been released yet.
1) Version Two bridge study has not been released. It is a recently acquired update to the original test.
2) Verification from a third party group will need to be done as well. We are currently working with BD but no percentages on spec of the new test has been released.
3) Data is supposed to be released in the upcoming weeks. A CLIA partner and a 12 week study should help verify LYMPRO.
I hope this answers your question. This board has some really good members that know way more than me. Warp, Dave, Tanis just to mention a few.
1) Version Two bridge study has not been released. It is a recently acquired update to the original test.
2) Verification from a third party group will need to be done as well. We are currently working with BD but no percentages on spec of the new test has been released.
3) Data is supposed to be released in the upcoming weeks. A CLIA partner and a 12 week study should help verify LYMPRO.
I hope this answers your question. This board has some really good members that know way more than me. Warp, Dave, Tanis just to mention a few.
(0)
(0)Amarantus Bioscience Holdings (AMBS) Stock Research Links
Scroll down for more posts ▼